Hepatitis B virus (HBV) chronic infection is responsible for almost 900.000 deaths each year,
due to cirrhosis or hepatocellular carcinoma (HCC). Ten HBV genotypes have been …

The selection pressure imposed by the host immune system impacts on hepatitis B virus
(HBV) variability. This study evaluates HBV genetic diversity, nucleos (t) ide analogs …

With a widespread distribution but low prevalence worldwide, the hepatitis B virus (HBV)
genotype G (HBV/G) is a recently described genotype for which the origin and biology are …

Hepatitis B virus (HBV) is one of the leading causes of acute and chronic hepatitis and
represents a serious public health threat. Cytokines are important chemical mediators that …

Hepatitis B virus (HBV) subgenotypes may be related to clinical outcomes and response to
antiviral therapy. Most Brazilian studies on HBV subgenotypes are restricted to some …

Hepatitis B virus (HBV) is a global public health problem and requires specific prevention
actions, particularly focusing on the key populations, such as men who have sex with men …

Hepatitis B virus (HBV) diagnosis is performed on serum samples, but the access to this
diagnosis is difficult in low-income regions. The use of dried blood spot (DBS) samples does …

Background Nucleic acid testing (NAT) for virus detection during blood screening has
helped to prevent transfusion-transmitted infections worldwide. In northern Brazil, NAT was …

Hepatitis B virus (HBV) genotype D (HBV/D) is globally widespread, and ten subgenotypes
(D1 to D10) showing distinct geographic distributions have been described to date. The …

Background Prison populations are at high risk for hepatitis B virus (HBV) infection. The aim
of this study was to assess the prevalence, incidence, HBV associated factors and …